Unstable angina and NSTEMI: early management

New evidence for CG94

We found 6 new studies in a search for systematic reviews published between 10 May 2012 and 26 January 2016. We also considered 2 additional studies identified by members of the guideline committee who originally worked on this guideline.

Evidence identified in previous surveillance 2 years after publication of the guideline was also considered. This included 76 studies identified by search. No studies were identified in comments received during consultation on the 2-year surveillance decision.

From all sources, 84 studies were considered to be relevant to the guideline.

We also checked for relevant ongoing research, which will be evaluated again at the next surveillance review of the guideline.

See appendix A1: summary of new evidence from surveillance and references for all new evidence considered.

New evidence for CG167

We found 123 new studies in a search for RCTs published between 1 November 2012 and 22 January 2016. We also considered 1 additional study identified by members of the guideline committee who originally worked on this guideline.

From all sources, 124 studies were considered to be relevant to the guideline.

We also checked for relevant ongoing research, which will be evaluated again at the next surveillance review of the guideline.

See appendix A2: summary of new evidence from surveillance and references for all new evidence considered.

Views of topic experts

We considered the views of topic experts, including those who helped to develop the guideline and other correspondence we have received since the publication of the guideline.

Views of stakeholders

Stakeholders are consulted only if we decide to update the guideline following checks at 4 and 8 years after publication. Because 2- and 6-year surveillance reviews were performed, and the decision was to update both guidelines, we did not consult on the decision.

See ensuring that published guidelines are current and accurate in 'Developing NICE guidelines: the manual' for more details on our consultation processes.

NICE Surveillance programme project team

Sarah Willett
Associate Director

Philip Alderson
Consultant Clinical Adviser

Katrina Sparrow
Technical Adviser

Jeffrey T Essuman
Technical Analyst

The NICE project team would like to thank the topic experts who participated in the surveillance process.

ISBN: 978-1-4731-2061-7